Drugs and Devices

FDA releases recommendations to reduce risk of Zika virus blood transmission

On Feb. 17, the Food and Drug Administration (FDA) issues recommendations to reduce the risk of transmission of the Zika virus through blood transfusion. The FDA recommends deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares